UNSPSC 85816116: Introduction of blood brain barrier disruption substance into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of blood brain barrier disruption substance into peripheral artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E053GN

UNSPSC 85816116, Introduction of blood brain barrier disruption substance into peripheral artery, percutaneous approach, is a Commodity code with no recent state and local contract opportunities that align with its nominal clinical scope. The recent opportunities tagged to this code span virtual urgent care, medical director services, PACE operations, cancer registry work, handheld retinal screening, EMS staffing, occupational health clinics, histology labs, travel nurse staffing, independent medical evaluations, and diverse other health services—none of which involve interventional neurology or blood-brain barrier manipulation. The code sees little relevant recent activity; state and local issuers do not appear to use this taxonomy code for their actual procurement needs in health services contracting.

The mismatch between the code's name and the work actually being solicited signals either that procurement offices are applying the wrong code designation or that the code itself is rarely used in state and local settings. Business development professionals evaluating this code should not pursue it on the assumption that posted opportunities align with the nominal scope. Verify the correct UNSPSC classification for any target opportunity before committing resources to pursuit.